Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Two Day Metered Dose Inhaler (MDI) Technology Seminar - London, United Kingdom - September 18-19, 2019 - ResearchAndMarkets.com

May 23, 2019 GMT

DUBLIN--(BUSINESS WIRE)--May 23, 2019--

The “Metered Dose Inhaler (MDI) Technology” conference has been added to ResearchAndMarkets.com’s offering.

A comprehensive overview of MDIs including development, manufacture, regulation and market potential


This interactive seminar will provide a comprehensive overview of metered-dose inhaler technology. It will clarify the therapeutic targets and look at delivery technologies. Participants will gain a valuable insight into market potential and receive detailed information on the manufacturing process, quality and inspection requirements and the regulatory pathways to follow.

This seminar will be beneficial for those new to the area and those who require a refresher on the opportunities with this technology. The seminar format will include practical workshops and there will be plenty of opportunity for discussion with the trainer who has significant experience in this field.

Who Should Attend:

  • Respiratory pharma professionals who need to understand MDI technology and its opportunities
  • Medical device professionals new to working in the area of MDIs or those who need a refresher
  • Medical device business development managers
  • Respiratory professionals in R & D
  • Medical device manufacturers working in the respiratory market


Programme Day One

Therapeutic targets

  • Very brief history
  • Asthma
  • COPD
  • Other local
  • CF
  • Systemic
  • Why?
  • Why not?
  • Key characteristics
  • Particle size
  • Why?


  • Disease distribution
  • Historic
  • Current
  • Future
  • Drivers
  • Manufacture vs use
  • International procurement - Double and triple counting
  • Regulation
  • Geographic differences
  • Pricing
  • vs cost
  • vs market - vs product

Delivery technologies

  • Inhalation
  • MDI
  • DPI: unit dose, multi-dose, reservoir
  • Nebuliser: energy source, SMI, other
  • Other
  • Oral
  • Injectable - Nasal
  • Cost considerations - Design
  • Scale
  • Investment
  • Cost of goods
  • Typical breakdown
  • Sensitivities


  • Ranking of competitive technologies for different opportunities

Programme Day Two

The MDI - overview

  • Hardware
  • Valves
  • Canister
  • Actuators
  • Sources
  • Formulations
  • Solution
  • Suspensions
  • Other

The MDI - manufacturing process

  • Process
  • Single-stage
  • Multi-stage
  • Cold
  • Flow
  • Areas

The MDI - manufacturing equipment

  • Scale
  • Lab
  • Small
  • Medium
  • Large

The MDI - quality and inspection

  • Incoming
  • Release

The MDI - other performance

  • Prime and re-prime
  • Thermal

Challenges and opportunities for the MDI - development and technical

  • Performance
  • Stability
  • Compatibility
  • Hardware availability
  • Manufacturing processes/equipment

Challenges and opportunities for the MDI and DPI

  • Co-ordination
  • Breath actuation
  • Training
  • Breath co-ordination
  • Deposition
  • Spacers
  • Holding chambers
  • Enhancements
  • Changing therapeutic approaches
  • Once daily
  • Combinations

Workshop (including coffee break)

  • SWOT MDI vs multi-dose DPI
  • SWOT MDI vs Soft Mist Inhaler

Regulation of inhalation products

  • Regulatory landscape (EU, US, RoW)
  • Generic
  • New combination
  • New chemical entity
  • Time to market
  • Success rate
  • Key expectations
  • Changing environment
  • Combination product approaches
  • Human factors
  • Bioequivalence

For more information about this conference visit https://www.researchandmarkets.com/r/fbw6h

View source version on businesswire.com:https://www.businesswire.com/news/home/20190523005337/en/

CONTACT: ResearchAndMarkets.com


Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Inhalers and Nebulisers,Respiratory Devices



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 05/23/2019 07:28 AM/DISC: 05/23/2019 07:28 AM